Metformin ER



Indications and Reactions:

Role Indications Reactions
Primary
Diabetes Mellitus Non-insulin-dependent 25.0%
Glucose Tolerance Impaired 25.0%
Polycystic Ovaries 25.0%
Type 1 Diabetes Mellitus 25.0%
Diarrhoea 20.0%
Headache 20.0%
Pharmaceutical Product Complaint 20.0%
Pruritus 20.0%
Therapeutic Response Unexpected With Drug Substitution 20.0%
Secondary
Drug Use For Unknown Indication 75.0%
Hypertension 25.0%
Angioedema 33.3%
Medication Error 33.3%
Vision Blurred 33.3%
Concomitant
Product Used For Unknown Indication 39.2%
Type 2 Diabetes Mellitus 10.4%
Diabetes Mellitus 7.5%
Hypertension 6.8%
Depression 3.3%
Gastrooesophageal Reflux Disease 3.0%
Asthma 2.7%
Blood Cholesterol Increased 2.7%
Hypersensitivity 2.7%
Pain 2.7%
Rheumatoid Arthritis 2.5%
Drug Use For Unknown Indication 2.3%
Chronic Obstructive Pulmonary Disease 2.2%
Insomnia 2.0%
Headache 1.8%
Hepatitis C 1.8%
Anxiety 1.7%
Diabetes Mellitus Non-insulin-dependent 1.7%
Bipolar Disorder 1.5%
Blood Cholesterol 1.5%
Weight Decreased 13.6%
Vomiting 12.1%
Pulmonary Embolism 10.6%
Nausea 6.1%
Off Label Use 6.1%
Pain 6.1%
Respiratory Tract Congestion 4.5%
Somnolence 4.5%
Blood Glucose Abnormal 3.0%
Blood Glucose Decreased 3.0%
Blood Glucose Increased 3.0%
Death 3.0%
Drug Ineffective 3.0%
Injection Site Haemorrhage 3.0%
Local Swelling 3.0%
Nasopharyngitis 3.0%
Palpitations 3.0%
Pneumonia 3.0%
Presyncope 3.0%
Product Quality Issue 3.0%